- Home
- VERB vs CMND Comparison
VERB vs CMND Comparison
Compare VERB & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERB
- CMND
- Stock Information
- Founded
- VERB 2014
- CMND 2017
- Country
- VERB United States
- CMND Canada
- Employees
- VERB N/A
- CMND N/A
- Industry
- VERB Other Consumer Services
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- VERB Consumer Discretionary
- CMND Health Care
- Exchange
- VERB Nasdaq
- CMND Nasdaq
- Market Cap
- VERB 5.8M
- CMND 4.8M
- IPO Year
- VERB N/A
- CMND N/A
- Fundamental
- Price
- VERB $7.32
- CMND $0.85
- Analyst Decision
- VERB Strong Buy
- CMND
- Analyst Count
- VERB 1
- CMND 0
- Target Price
- VERB $62.00
- CMND N/A
- AVG Volume (30 Days)
- VERB 42.6K
- CMND 122.4K
- Earning Date
- VERB 08-13-2025
- CMND 06-12-2025
- Dividend Yield
- VERB N/A
- CMND N/A
- EPS Growth
- VERB N/A
- CMND N/A
- EPS
- VERB N/A
- CMND N/A
- Revenue
- VERB $2,193,000.00
- CMND N/A
- Revenue This Year
- VERB $526.82
- CMND N/A
- Revenue Next Year
- VERB $45.45
- CMND N/A
- P/E Ratio
- VERB N/A
- CMND N/A
- Revenue Growth
- VERB 3125.00
- CMND N/A
- 52 Week Low
- VERB $3.81
- CMND $0.80
- 52 Week High
- VERB $27.14
- CMND $2.30
- Technical
- Relative Strength Index (RSI)
- VERB 52.71
- CMND 41.60
- Support Level
- VERB $6.38
- CMND $0.83
- Resistance Level
- VERB $7.15
- CMND $0.93
- Average True Range (ATR)
- VERB 0.68
- CMND 0.06
- MACD
- VERB -0.17
- CMND 0.00
- Stochastic Oscillator
- VERB 25.90
- CMND 32.64
About VERB Verb Technology Company Inc.
Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.